Ebola-Behandlung | Düsseldorfer Isolierstation wäre in vier Stunden bereit

Sie ist eine von nur sieben Stationen bundesweit, die hochansteckende Personen oder Verdachtsfälle aufnehmen und behandeln kann.

WDR
Ebola-Behandlung | Düsseldorfer Isolierstation wäre in vier Stunden bereit

Sie ist eine von nur sieben Stationen bundesweit, die hochansteckende Personen oder Verdachtsfälle aufnehmen und behandeln kann.

WDR
#Nosocomial #outbreak of #Lassa fever in Conakry, #Guinea, 2022

The virus entry #inhibitor ARN-75039 provides therapeutic #protection against #Lassa virus infection in guinea pigs, https://etidiohnew.blogspot.com/2026/04/the-virus-entry-inhibitor-arn-75039.html
The virus entry #inhibitor ARN-75039 provides therapeutic #protection against #Lassa virus infection in guinea pigs

Post-discharge #sequelae of #Lassa fever #survivors in #Nigeria: an analysis of the LASCOPE prospective cohort, https://etidiohnew.blogspot.com/2026/03/post-discharge-sequelae-of-lassa-fever.html
Post-discharge #sequelae of #Lassa fever #survivors in #Nigeria: an analysis of the LASCOPE prospective cohort

#Lassa fever #symptomatology, viral dynamics, and host immune response (PREPARE): a prospective, observational cohort study in #Liberia, https://etidiohnew.blogspot.com/2026/01/lassa-fever-symptomatology-viral.html
#Lassa fever #symptomatology, viral dynamics, and host immune response (PREPARE): a prospective, observational cohort study in #Liberia

Safety, tolerability, and immunogenicity of INO-4500, a synthetic #DNA-based #vaccine against #Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults, https://etidiohnew.blogspot.com/2025/11/safety-tolerability-and-immunogenicity.html
Safety, tolerability, and immunogenicity of INO-4500, a synthetic #DNA-based #vaccine against #Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults

#Safety and Immunogenicity of an rVSV #Lassa Fever #Vaccine Candidate

#Lassa Virus #Infection of Primary #Human #Airway Epithelial Cells